Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(8 sites)
Finland
Turku University Hospital, Turku Norway
Haukeland University Hospital, Bergen Akershus University Hospital, Oslo Ullevål University Hospital, Oslo Stavanger University Hospital, Stavanger University Hospital of North Norway, Tromsø St Olavs Hospital, Trondheim Sweden
Karolinska Universitetssjukhuset, Stockholm